Compugen (CGEN) Competitors $1.38 -0.02 (-1.43%) Closing price 04:00 PM EasternExtended Trading$1.39 +0.01 (+0.72%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CGEN vs. ETON, ARCT, EOLS, NBTX, RGNX, ALMS, ITOS, REPL, ERAS, and PRTAShould you be buying Compugen stock or one of its competitors? The main competitors of Compugen include Eton Pharmaceuticals (ETON), Arcturus Therapeutics (ARCT), Evolus (EOLS), Nanobiotix (NBTX), REGENXBIO (RGNX), Alumis (ALMS), iTeos Therapeutics (ITOS), Replimune Group (REPL), Erasca (ERAS), and Prothena (PRTA). These companies are all part of the "pharmaceutical products" industry. Compugen vs. Its Competitors Eton Pharmaceuticals Arcturus Therapeutics Evolus Nanobiotix REGENXBIO Alumis iTeos Therapeutics Replimune Group Erasca Prothena Compugen (NASDAQ:CGEN) and Eton Pharmaceuticals (NASDAQ:ETON) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability. Is CGEN or ETON more profitable? Eton Pharmaceuticals has a net margin of -7.10% compared to Compugen's net margin of -87.45%. Eton Pharmaceuticals' return on equity of -0.73% beat Compugen's return on equity.Company Net Margins Return on Equity Return on Assets Compugen-87.45% -34.77% -16.82% Eton Pharmaceuticals -7.10%-0.73%-0.22% Do analysts recommend CGEN or ETON? Compugen currently has a consensus price target of $4.00, suggesting a potential upside of 189.86%. Eton Pharmaceuticals has a consensus price target of $29.67, suggesting a potential upside of 47.30%. Given Compugen's higher probable upside, equities research analysts plainly believe Compugen is more favorable than Eton Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Compugen 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Eton Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of CGEN or ETON? 12.2% of Compugen shares are held by institutional investors. Comparatively, 27.9% of Eton Pharmaceuticals shares are held by institutional investors. 9.5% of Compugen shares are held by insiders. Comparatively, 16.0% of Eton Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media favor CGEN or ETON? In the previous week, Eton Pharmaceuticals had 4 more articles in the media than Compugen. MarketBeat recorded 5 mentions for Eton Pharmaceuticals and 1 mentions for Compugen. Compugen's average media sentiment score of 1.89 beat Eton Pharmaceuticals' score of 0.84 indicating that Compugen is being referred to more favorably in the media. Company Overall Sentiment Compugen Very Positive Eton Pharmaceuticals Positive Which has stronger earnings and valuation, CGEN or ETON? Eton Pharmaceuticals has higher revenue and earnings than Compugen. Eton Pharmaceuticals is trading at a lower price-to-earnings ratio than Compugen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCompugen$27.86M4.42-$14.23M-$0.22-6.27Eton Pharmaceuticals$39.01M13.85-$3.82M-$0.16-125.88 Which has more volatility & risk, CGEN or ETON? Compugen has a beta of 2.58, indicating that its share price is 158% more volatile than the S&P 500. Comparatively, Eton Pharmaceuticals has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500. SummaryEton Pharmaceuticals beats Compugen on 11 of the 15 factors compared between the two stocks. Get Compugen News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CGEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CGEN vs. The Competition Export to ExcelMetricCompugenMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$124.93M$3.13B$5.75B$10.39BDividend YieldN/A2.39%5.75%4.64%P/E Ratio-6.2720.6375.7726.11Price / Sales4.42442.69544.74124.93Price / CashN/A44.6737.5461.24Price / Book2.239.6212.876.30Net Income-$14.23M-$52.73M$3.29B$271.03M7 Day Performance2.99%0.64%-0.26%-0.15%1 Month Performance-3.50%6.31%3.84%6.41%1 Year Performance-20.69%18.97%68.35%28.81% Compugen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CGENCompugen1.5588 of 5 stars$1.38-1.4%$4.00+189.9%-20.5%$124.93M$27.86M-6.2770Positive NewsETONEton Pharmaceuticals2.0349 of 5 stars$17.78+0.7%$29.67+66.9%+246.6%$473.33M$39.01M-111.1320Positive NewsARCTArcturus Therapeutics2.7113 of 5 stars$18.13+4.7%$50.57+178.9%-5.9%$470.32M$152.31M-8.13180EOLSEvolus4.0057 of 5 stars$6.63-7.8%$21.25+220.5%-61.4%$465.09M$266.27M-6.77170NBTXNanobiotix0.8035 of 5 stars$9.32-3.9%$8.00-14.2%+241.8%$464.99M$39.18M0.00100Upcoming EarningsGap DownRGNXREGENXBIO4.6128 of 5 stars$9.09-1.2%$28.38+212.2%-14.9%$464.73M$83.33M-2.64370Positive NewsALMSAlumis3.468 of 5 stars$4.38+0.2%$20.17+360.4%-63.8%$454.76MN/A0.00N/APositive NewsITOSiTeos Therapeutics2.682 of 5 stars$10.15flat$15.50+52.7%N/A$448.73M$35M-2.1790Positive NewsREPLReplimune Group4.4995 of 5 stars$5.67-1.0%$6.50+14.6%-62.4%$447.26MN/A-1.75210ERASErasca2.4284 of 5 stars$1.60+2.6%$3.71+132.1%-24.7%$442.52MN/A-3.56120PRTAProthena3.108 of 5 stars$8.16-0.6%$19.75+142.0%-57.7%$441.94M$135.16M-1.45130Positive News Related Companies and Tools Related Companies Eton Pharmaceuticals Alternatives Arcturus Therapeutics Alternatives Evolus Alternatives Nanobiotix Alternatives REGENXBIO Alternatives Alumis Alternatives iTeos Therapeutics Alternatives Replimune Group Alternatives Erasca Alternatives Prothena Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CGEN) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compugen Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Compugen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CGEN Stock Alerts